Navigation Links
Endo Pharmaceuticals to Present at Goldman Sachs 30th Annual Healthcare Conference
Date:6/5/2009

CHADDS FORD, Pa., June 5 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) announced today that it will present at the Goldman Sachs 30th Annual Healthcare Conference on Wednesday, June 10, 2009 at 4:30 pm Eastern Time. Dave Holveck, President and Chief Executive Officer of Endo, will review the company's products and development programs.

The presentation will be webcast live and can be accessed from Endo's website at www.endo.com under the investors section.

About Endo

Endo Pharmaceuticals is a specialty pharmaceutical company engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used to treat and manage pain, overactive bladder, prostate cancer and the early onset of puberty in children, or central precocious puberty (CPP). Its products include LIDODERM(R), a topical patch to relieve the pain of postherpetic neuralgia; Percocet(R) and Percodan(R) tablets for the relief of moderate-to-moderately severe pain; FROVA(R) tablets for the acute treatment of migraine attacks with or without aura in adults; OPANA(R) tablets for the relief of moderate-to-severe acute pain where the use of an opioid is appropriate; OPANA(R) ER tablets for the relief of moderate-to-severe pain in patients requiring continuous, around-the-clock opioid treatment for an extended period of time; and Voltaren(R)Gel, a nonsteroidal anti-inflammatory drug indicated for the relief of the pain of osteoarthritis of joints amenable to topical treatment, such as those of the hands and the knees. Voltaren(R)Gel is owned and licensed by Novartis AG; SANCTURA(R) and its XR version for treatment of overactive bladder, VANTAS(R) for the palliative treatment of advanced prostate cancer, and SUPPRELIN(R) LA for the treatment of
'/>"/>

SOURCE Endo Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Isis Pharmaceuticals to Present at Needhams 8th Annual Life Sciences Conference
2. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Needham Life Sciences Conference in New York on June 11, 2009
3. Anadys Pharmaceuticals, Inc. Announces Pricing of Common Stock and Warrant Offering
4. Isis Pharmaceuticals to Present at Goldman Sachs 30th Annual Global Healthcare Conference
5. ISTA Pharmaceuticals Announces FDA Advisory Committee to Review Bepreve(TM) for the Treatment of Ocular Itching Associated with Allergic Conjunctivitis
6. Access Pharmaceuticals Provides Update on ProLindac(TM) Phase 2 Ovarian Cancer Trial and Clinical Development Plan
7. SAFC(R) & Cherokee Pharmaceuticals(TM) Pool Expertise and Resources With Strategic Partnership For U.S. Market
8. Vanda Pharmaceuticals Announces Date of Annual Meeting of Stockholders
9. West Pharmaceutical Services to Present at the 2009 UBS Global Specialty Pharmaceuticals Conference
10. AUDIO from Medialink, Bayer Healthcare and Onyx Pharmaceuticals: Facts About Hepatitis
11. Vion Pharmaceuticals to Present Data on Onrigin(TM)at the ASCO(R) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... (PRWEB) May 06, 2015 Established by ... wellness for the estimated 46 million Americans who suffer ... upon monthly medications to alleviate their symptoms. Medicationdiscountcard.com is ... to save patients money on the costs of these ... are used to treat the pain and inflammation in ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 The American ... nomination period for its prestigious Integrated Water Resources Management ... IWRM approach to water resources projects. , An IWRM approach ... our establishment in 1964. In 2014, 12 projects were nominated ... IMPACT magazine features not only the 2014 AWRA IWRM Award ...
(Date:5/6/2015)... Wethersfield, Conn. (PRWEB) May 06, 2015 ... company in Wethersfield, Conn., has hired healthcare executive ... vice president. Olson will lead Qualidigm’s growing ... further Qualidigm’s mission to improve the quality, safety, ... Olson comes to Qualidigm from Interim HealthCare of ...
(Date:5/6/2015)... 2015 Novodiax announced today that ... of Innovations with Ed Begley Jr., airing via ... times TBA. , This segment will explore Novodiax, ... diagnostics. Audiences will learn about Novodiax’s polymer detection ... behind the scenes to investigate how, based on ...
(Date:5/6/2015)... The Center for Innovative Technology (CIT) announced ... e-Kare, Inc. of Fairfax, VA, a digital health company ... wounds. , Chronic wounds include pressure, venous, and diabetic ... over 6.5 million U.S. patients, costing over $25 billion. ... the Children’s National Medical Center (CNMC), e-Kare ...
Breaking Medicine News(10 mins):Health News:Medicationdiscountcard.com Provides Access to Drug Coupons for Arthritis Awareness Month 2Health News:Medicationdiscountcard.com Provides Access to Drug Coupons for Arthritis Awareness Month 3Health News:Nominations Sought for Integrated Water Resources Management (IWRM) Award 2Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 2Health News:Innovative Healthcare Executive Ann Olson Joins Qualidigm as Principal and Vice President 3Health News:Novodiax to Be Featured in Upcoming Episode of Innovations TV Series 2Health News:CIT GAP Funds Invests in e-Kare 2Health News:CIT GAP Funds Invests in e-Kare 3
... Clearly Contacts, the ... BC Business Magazines, Top 100 Public Companies list for the fifth consecutive year. Clearly ... with revenue of $119 million for fiscal 2008. , ... Vancouver, British Columbia (Vocus) June 30, 2009 -- Clearly Contacts ...
... ... editor-in-chief of Orthopaedic Knowledge Online, William A. Grana, MD, MPH, will be inducted into ... July 11th during its Annual Meeting in Keystone, Colorado. , ... Keystone, CO (Vocus) June 30, 2009 ...
... Limited (Chiltern), a global clinical research organization (CRO) announced that ... , , Dr. Attila Lorinczi will lead ... Medical Society and the Society of Hungarian Urologists. Dr. Lorinczi ... years, most recently as a clinical operations manager. , ...
... Oxford University Press is proud to present the ... AMA Manual of Style, the "bible" ... involved in medical or scientific publishing. Because scientific, medical, and ... a new treatment hinges on how well the evidence to ...
... , MINNEAPOLIS, June 29 HealthFitness Corporation (NYSE ... employee health and productivity management solutions, announced today that the ... the close of market on June 26, 2009, when Russell ... indexes. , , About HealthFitness , ...
... in doctor,s office, for example, at risk, study shows , ... blood pressure that can happen in a doctor,s office, or ... sustained high blood pressure, a new study finds. , Researchers ... In white-coat hypertension, a patient,s blood pressure is high while ...
Cached Medicine News:Health News:Clearly Contacts Named to BC Business Magazine Top 100 Public Companies List 2Health News:Teacher and Profession Leader, William A. Grana, MD, MPH, Inducted into Sports Medicine Hall of Fame 2Health News:Teacher and Profession Leader, William A. Grana, MD, MPH, Inducted into Sports Medicine Hall of Fame 3Health News:Chiltern Opens Office in Budapest, Hungary 2Health News:AMA Manual of Style, the 'Bible' for Medical and Scientific Publishing, Gains Online Presence 2Health News:HealthFitness Added to the Russell Microcap Index 2Health News:Sporadic Spikes in Blood Pressure Hike Chances of Hypertension 2
(Date:5/6/2015)... Calif. , May 6, 2015  Genomic Health, ... Kim Popovits , Chairman of the Board, Chief Executive ... America Merrill Lynch 2015 Healthcare Conference in ... 3:40 p.m. Pacific Time (PT). To access ... go to the  Investor Relations  section of the company,s ...
(Date:5/6/2015)... 6, 2015  Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ... development and commercialization of a once-daily, oral therapy for ... today that it will host a conference call and ... for the period ended March 31, 2015 and to ... its clinical program for aramchol. Conference ...
(Date:5/6/2015)... May 6, 2015 Neuralstem, Inc. (NYSE MKT: ... to develop small molecule and cell therapy treatments for ... Jonathan Lloyd Jones to the position of Chief ... Mr. Lloyd Jones brings to the ... business development experience.   Most recently, Mr. Lloyd Jones ...
Breaking Medicine Technology:Genomic Health to Present at the Bank of America Merrill Lynch 2015 Healthcare Conference 2Genomic Health to Present at the Bank of America Merrill Lynch 2015 Healthcare Conference 3Galmed Pharmaceuticals First Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, May 13, 2015 2Galmed Pharmaceuticals First Quarter 2015 Conference Call and Webcast Scheduled for Wednesday, May 13, 2015 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 2Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 3Neuralstem Appoints Jonathan Lloyd Jones as Chief Financial Officer 4
... Novel Biomarkers Displaying 90% Sensitivity in Breast ... ... announced today the,discovery and validation of the most frequent DNA alterations detected ... appeared in PLoS ONE. The study entitled, "Identification of,Novel High-Frequency DNA Methylation ...
... GeoVax Labs, Inc. (OTC,Bulletin Board: GOVX), an Atlanta-based ... has retained Financial,Relations Board (FRB), as its Investor ... HIV-1/AIDS vaccine human trial results need to be,conveyed ... AIDS,pandemic," stated Kathy Waller, co-president of FRB., ...
Cached Medicine Technology:Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers 2GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel 2GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel 3GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel 4
Duckbill type, sharp. 3 mm x 8 mm curved blade. Octagonal handle....
10 mm wide tip....
9 mm wide tip. 35 mm from angle to tip....
Designated most popular model or size. 4 mm wide tip....
Medicine Products: